Residual inflammatory risk is major driver of CV events and mortality in statin-treated patients3' education - Mar. 7, 2023 - Prof. Paul Ridker, MD - Boston, MA, USA
This video was recorded at the Congress of the American College of Cardiology (ACC) 2023 in New Orleans, LA, USA.
Paul M Ridker is the Eugene Braunwald Professor of Medicine at the Harvard Medical School and directs the Center for Cardiovascular Disease Prevention, a translational research unit at the Brigham and Women’s Hospital in Boston, MA, USA.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.